Access the full text.
Sign up today, get DeepDyve free for 14 days.
Gerald Nabozny, S. Cobbold, H. Waldmann, Y. Kong (1991)
Suppression in murine experimental autoimmune thyroiditis: in vivo inhibition of CD4+ T cell-mediated resistance by a nondepleting rat CD4 monoclonal antibody.Cellular immunology, 138 1
I. Bank, L. Chess (1985)
Perturbation of the T4 molecule transmits a negative signal to T cellsThe Journal of Experimental Medicine, 162
Tchobroutsky Tchobroutsky (1978)
Relation of diabetic control to development of microvascular complicationsDiabetologia, 15
X. Lu, J. Borel (1995)
Prolongation of islet xenograft survival with combined treatment of 15-deoxyspergualin or cyclosporine and anti-CD4 monoclonal antibody.Transplantation proceedings, 27 1
Judith Shiztru, S. Alters, C. Fathman (1992)
Anti‐CD4 Monoclonal Antibodies in Therapy: Creation of Nonclassical Tolerance in the AdultImmunological Reviews, 129
M. Ahn, C. Sohn, E. Chang, G. Chu, R. DeMatteo, C. Barker, J. Markmann (1996)
Role of humoral immunity in pancreatic islet allo- and xenograft rejection.Transplantation proceedings, 28 2
J. Hayes, J. Hayes (1993)
The immunobiology and clinical use of current immunosuppressive therapy for renal transplantation.The Journal of urology, 149 3
E. Bolton, J Gracie, J Briggs, J. Kampinga, J. Bradley (1989)
Cellular requirements for renal allograft rejection in the athymic nude ratThe Journal of Experimental Medicine, 169
Zonghua Chen, S. Cobbold, S. Metcalfe, H. Waldmann (1992)
Tolerance in the mouse to major histocompatibility complex‐mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8European Journal of Immunology, 22
S. Cobbold, H. Waldmann (1986)
Skin allograft rejection by L3/T4+ and Lyt-2+ T cell subsets.Transplantation, 41 5
M. Dallman, D. Mason, M. Webb (1982)
The roles of host and donor cells in the rejection of skin allografts by T cell‐deprived rats injected with syngeneic T cellsEuropean Journal of Immunology, 12
Honey Honey, Charlton Charlton, Wood Wood (1991)
Rat brain xenografts reverse hypogonadism in mice immunosuppressed with anti‐CD4 monoclonal antibodyExp Brain Res, 85
J. Wheelahan, I. McKenzie (1987)
THE ROLE OF T4+ AND LY‐2+ CELLS IN SKIN GRAFT REJECTION IN THE MOUSETransplantation, 44
J. Binder, M. Lehmann, E. Graser, W. Hancock, B. Watschinger, K. Onodera, M. Sayegh, H. Volk, J. Kupiec-Weglinski (1996)
The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.Transplantation, 61 5
C. Darby, P. Morris, K. Wood (1992)
EVIDENCE THAT LONG‐TERM CARDIAC ALLOGRAFT SURVIVAL INDUCED BY ANTI‐CD4 MONOCLONAL ANTIBODY DOES NOT REQUIRE DEPLETION OF CD4+ T CELLSTransplantation, 54
(1993)
Status of islet cell transplantation
Ahn Ahn, Sohn Sohn, Chang Chang, Chu Chu, Dematteo Dematteo, Barker Barker, Markmann Markmann (1996)
Role of humoral immunity in pancreatic islet allo‐ and xenograft rejectionTansplant Proc, 28
C. Darby, A. Bushell, P. Morris, K. Wood (1994)
Nondepleting anti-CD4 antibodies in transplantation. Evidence that modulation is far less effective than prolonged CD4 blockade.Transplantation, 57 10
D. Yasmeen, J. Ellerson, K. Dorrington, R. Painter (1976)
The Structure and Function of Immunoglobulin Domains: IV. The Distribution of Some Effector Functions Among the Cγ2 and Cγ3 Homology Regions of Human Immunoglobulin GJournal of Immunology, 116
Yasmeen Yasmeen, Ellerson Ellerson, Dorrington Dorrington, Painter Painter (1976)
The structure and function of immunoglobulin domainsJ Immunol, 116
R. Pierson, Henry Winn, P. Russell, H. Auchincloss (1989)
Xenogeneic skin graft rejection is especially dependent on CD4+ T cellsThe Journal of Experimental Medicine, 170
A. Carrera, F. Sánchez‐Madrid, M. López-Botet, C. Bernabéu, M. Landázuri (1987)
Involvement of the CD4 molecule in a post‐activation event on T cell proliferationEuropean Journal of Immunology, 17
G. Horneff, G. Burmester, F. Emmrich, J. Kalden (1991)
Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody.Arthritis and rheumatism, 34 2
P. Lubbe, C. Reiter, F. Breedveld, Klaus Kr¨ger, M. Schattenkirchner, M. Sanders, Gert Riethm¨ller (1993)
Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis.Arthritis and rheumatism, 36 10
T. Mandel, H. Dillon, M. Koulmanda (1995)
The effect of a depleting anti-CD4 monoclonal antibody on T cells and fetal pig islet xenograft survival in various strains of mice.Transplant immunology, 3 3
D. Mason, P. Morris (1986)
Effector mechanisms in allograft rejection.Annual review of immunology, 4
M. Gotoh, T. Maki, T. Kiyoizumi, S. Satomi, A. Monaco (1985)
An improved method for isolation of mouse pancreatic islets.Transplantation, 40 4
F. Mazerolles, C. Auffray, A. Fischer (1991)
Down regulation of T-cell adhesion by CD4.Human immunology, 31 1
G. Horneff, F. Emmrich, C. Reiter, J. Kalden, Gerd Burmester (1992)
Persistent depletion of CD4+ T cells and inversion of the CD4/CD8 T cell ratio induced by anti-CD4 therapy.The Journal of rheumatology, 19 12
T. Loudovaris, T. Mandel, B. Charlton (1996)
CD4+ T cell mediated destruction of xenografts within cell-impermeable membranes in the absence of CD8+ T cells and B cells.Transplantation, 61 12
B. Mueller, R. Reisfeld, S. Gillies (1990)
Serum half-life and tumor localization of a chimeric antibody deleted of the CH2 domain and directed against the disialoganglioside GD2.Proceedings of the National Academy of Sciences of the United States of America, 87
D. Saitovitch, A. Bushell, Duncan Mabbs, Peter Morris, Kathryn Wood (1996)
Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation. A critical period of time is required for development of immunological unresponsiveness.Transplantation, 61 11
Cosimi Ab, Francis Delmonico, Wright Jk, Wee Sl, FredericI. Preffer, Jolliffe Lk, Robert Colvin (1990)
Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody.Surgery, 108 2
S. Qin, M. Wise, S. Cobbold, L. Leong, Yi‐Chi Kong, J. Parnes, H. Waldmann (1990)
Induction of tolerance in peripheral T cells with monoclonal antibodiesEuropean Journal of Immunology, 20
H. Spiegelberg, W. Weigle (1965)
THE CATABOLISM OF HOMOLOGOUS AND HETEROLOGOUS 7S GAMMA GLOBULIN FRAGMENTSThe Journal of Experimental Medicine, 121
S. Cobbold, S. Qin, L. Leong, G. Martin, H. Waldmann (1992)
Reprogramming the Immune System for Peripheral Tolerance with CD4 and CD8 Monoclonal AntibodiesImmunological Reviews, 129
ABSTRACT: Xenogeneic grafts provide a potential alternative to the current shortage of human organs for transplantation. However, the prevention of rejection and tolerance induction of xenografts still remain to be further explored. Islet xenografts appear more promising than vascularized whole organ xenografts and additionally also more resistant to the recurrence of autoimmune disease than allografts. Recently, the nondepleting monoclonal antibody (mAb), which blocks the CD4 molecule on lymphocytes, was reported to be able to induce tolerance in allotransplantation and CD4 positive cells were further confirmed to be a major factor responsible for cellular xenograft rejection. Therefore, we hypothesize that anti‐CD4 nondepleting mAb could also be effective in protecting cellular xenografts and inducing unresponsiveness of recipients. We studied the effect of the nondepleting anti‐CD4 mAb YTS177.9 on islet xenograft survival by using the hamster‐to‐mouse islet transplantation model. Results were compared with that of the depleting anti‐CD4 mAb GK1.5 that was shown to have similar binding sites on the CD4 molecule to mAb YTS 177.9. Our data show that mAb YTS 177.9 did effectively prolong the survival of islet xenografts and, in addition, also successfully did induce long‐term acceptance of 40% grafts after only three penoperative injections of 0.5 mg mAb per mouse. The average survival of the graft was markedly prolonged to >66.8±37.1 days compared with controls (8.3±1.4 days) or with the depleting anti‐CD4 mAb GK1.5 (25.7±5.5 days). However, the latter displayed a more profound inhibition in in vitro and ex vivo mixed lymphocyte xenoreaction than mAb YTS 177.9. Moreover, the activity of this nondepleting mAb was found to be dose‐dependent and 80% of grafts survived permanently when the dose was increased to six injections of 0.5 mg mAb. Like mAb GK1.5, mAb YTS 177.9 also prevented rejection when given after a delay of two days posttransplant. In addition, we found that neither depleting nor nondepleting anti‐CD8 mAb was effective in this model. Our results strongly suggest that an anti‐CD4 nondepleting or blocking mAb alone is able to induce long‐term acceptance of islet xenografts and that blocking the CD4 molecule is significantly superior to depleting CD4 positive cells for the protection of islet xenografts. This may indicate that CD4 cells play a major role in xenograft tolerance induction.
Xenotransplantation – Wiley
Published: May 1, 1998
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.